Form 8-K - Current report:
SEC Accession No. 0001628280-24-041894
Filing Date
2024-10-02
Accepted
2024-10-02 16:18:10
Documents
17
Period of Report
2024-10-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20241002.htm   iXBRL 8-K 26662
2 EX-1.1 exhibit11-closing8xk10224.htm EX-1.1 250244
3 EX-5.1 exhibit51-closing8xk10224.htm EX-5.1 25876
7 image_0.jpg GRAPHIC 11449
8 image_1.jpg GRAPHIC 18133
  Complete submission text file 0001628280-24-041894.txt   523156

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20241002.xsd EX-101.SCH 1922
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20241002_lab.xml EX-101.LAB 21597
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20241002_pre.xml EX-101.PRE 12510
20 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20241002_htm.xml XML 2706
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Filer) CIK: 0001935979 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41477 | Film No.: 241347595
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)